[1] Moglad EH, Hassan AO, Elmanan MSA, et al. Seroepidemiological survey of cytomegalovirus infection among pregnant women in Sudan. Pol J Microbiol, 2023; 72, 269−75. doi:  10.33073/pjm-2023-026
[2] Wujcicka W, Gaj Z, Wilczyński J, et al. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis, 2014; 33, 1951−8. doi:  10.1007/s10096-014-2170-3
[3] Kling C, Kabelitz D. HCMV seroprevalence in couples under infertility treatment. Arch Gynecol Obstet, 2015; 292, 439−43. doi:  10.1007/s00404-015-3640-2
[4] Wieringa JW, De Vries JJC, Murk JL. Congenital CMV infections. Ned Tijdschr Geneeskd, 2013; 157, A6250.
[5] Ijezie EC, O'Dowd JM, Kuan MI, et al. HCMV infection reduces nidogen-1 expression, contributing to impaired neural rosette development in brain organoids. J Virol, 2023; 97, e01718−22.
[6] Sun XN, Guan YJ, Li FJ, et al. Effects of rat cytomegalovirus on the nervous system of the early rat embryo. Virol Sin, 2012; 27, 234−40. doi:  10.1007/s12250-012-3250-0
[7] Salomè S, Corrado FR, Mazzarelli LL, et al. Congenital cytomegalovirus infection: the state of the art and future perspectives. Front Pediatr, 2023; 11, 1276912. doi:  10.3389/fped.2023.1276912
[8] Ssentongo P, Hehnly C, Birungi P, et al. Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis. JAMA Netw Open, 2021; 4, e2120736. doi:  10.1001/jamanetworkopen.2021.20736
[9] Bianchi A, Coviello C, Leonardi V, et al. In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report. Ital J Pediatr, 2021; 47, 227. doi:  10.1186/s13052-021-01170-w
[10] Berkebile ZW, Putri DS, Abrahante JE, et al. The placental response to guinea pig cytomegalovirus depends upon the timing of maternal infection. Front Immunol, 2021; 12, 686415. doi:  10.3389/fimmu.2021.686415
[11] Adelman JW, Rosas-Rogers S, Schumacher ML, et al. Human cytomegalovirus induces significant structural and functional changes in terminally differentiated human cortical neurons. mBio, 2023; 14, e02251−23.
[12] Aronoff DM, Correa H, Rogers LM, et al. Placental pericytes and cytomegalovirus infectivity: implications for HCMV placental pathology and congenital disease. Am J Reprod Immunol, 2017; 78, e12728. doi:  10.1111/aji.12728
[13] Jones CJP, Desoye G. A new possible function for placental pericytes. Cells Tissues Organs, 2011; 194, 76−84. doi:  10.1159/000322394
[14] Zhang XW, Li F, Yu XW, et al. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol, 2007; 40, 180−5. doi:  10.1016/j.jcv.2007.08.018
[15] Singh G, Gaidhane A. A review of sensorineural hearing loss in congenital cytomegalovirus infection. Cureus, 2022; 14, e30703.
[16] Sison SL, O'Brien BS, Johnson AJ, et al. Human cytomegalovirus disruption of calcium signaling in neural progenitor cells and organoids. J Virol, 2019; 93.
[17] Odeberg J, Wolmer N, Falci S, et al. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J Neurosci Res, 2007; 85, 583−93. doi:  10.1002/jnr.21144
[18] Wu D, Yang L, Bu XS, et al. NMDA receptor subunit and CaMKII changes in rat hippocampus by congenital HCMV infection: a mechanism for learning and memory impairment. Neuroreport, 2017; 28, 253−8. doi:  10.1097/WNR.0000000000000750
[19] Nicoll RA, Schulman H. Synaptic memory and CaMKII. Physiol Rev, 2023; 103, 2877−925.
[20] Reddehase MJ, Lemmermann NAW. Mouse model of cytomegalovirus disease and immunotherapy in the immunocompromised host: predictions for medical translation that survived the "test of time". Viruses, 2018; 10, 693.
[21] Tomac J, Mazor M, Lisnić B, et al. Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility. Immunity, 2021; 54, 1478-93.
[22] Brizić I, Lisnić B, Brune W, et al. Cytomegalovirus infection: mouse model. Curr Protoc Immunol, 2018; 122, e51.
[23] Massara L, Khairallah C, Yared N, et al. Uncovering the anticancer potential of murine cytomegalovirus against human colon cancer cells. Mol Ther Oncolytics, 2020; 16, 250-61.
[24] Moulden J, Sung CYW, Brizic I, et al. Murine models of central nervous system disease following congenital human cytomegalovirus infections. Pathogens, 2021; 10, 1062.
[25] Sharma RP, Chopra VL. Effect of the wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev Biol, 1976; 48, 461-5.
[26] Khan M, Muzumdar D, Shiras A. Attenuation of tumor suppressive function of FBXO16 ubiquitin ligase activates Wnt signaling in glioblastoma. Neoplasia, 2019; 21, 106-16.
[27] Abdolmaleki F, Ahmadpour-Yazdi H, Hayat SMG, et al. Wnt network: a brief review of pathways and multifunctional components. Crit Rev Eukar Gene Expr, 2020; 30, 1-18.
[28] Becker J, Wilting J. WNT signaling in neuroblastoma. Cancers, 2019; 11, 1013.
[29] Zwezdaryk KJ, Combs JA, Morris CA, et al. Regulation of Wnt/β-catenin signaling by herpesviruses. World J Virol, 2016; 5, 144-54.
[30] Nie RX, Zhang WH, Tian HY, et al. Regulation of follicular development in chickens: WIF1 modulates granulosa cell proliferation and progesterone synthesis via Wnt/β-catenin signaling pathway. Int J Mol Sci, 2024; 25, 1788.
[31] Niida A, Hiroko T, Kasai M, et al. DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene, 2004; 23, 8520-6.
[32] Angelova M, Zwezdaryk K, Ferris M, et al. Human cytomegalovirus infection dysregulates the canonical Wnt/β-catenin signaling pathway. PLoS Pathog, 2012; 8, e1002959.
[33] Liu JQ, Xiao Q, Xiao JN, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Sig Transduct Target Ther, 2022; 7, 3.
[34] Tan QH, Otgonbaatar A, Kaur P, et al. The Wnt co-receptor PTK7/Otk and its homolog Otk-2 in neurogenesis and patterning. Cells, 2024; 13, 365.
[35] Munji RN, Choe Y, Li GN, et al. Wnt signaling regulates neuronal differentiation of cortical intermediate progenitors. J Neurosci, 2011; 31, 1676-87.
[36] Slawny NA, O'Shea KS. Dynamic changes in Wnt signaling are required for neuronal differentiation of mouse embryonic stem cells. Mol Cell Neurosci, 2011; 48, 205-16.
[37] Maruyama T, Mirando AJ, Deng CX, et al. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal, 2010; 3, ra40.
[38] Undi RB, Gutti U, Sahu I, et al. Wnt signaling: role in regulation of haematopoiesis. Indian J Hematol Blood Transfus, 2016; 32, 123-34.
[39] Sidrat T, Rehman ZU, Joo MD, et al. Wnt/β-catenin pathway-mediated PPARδ expression during embryonic development differentiation and disease. Int J Mol Sci, 2021; 22, 1854.
[40] Machon O, Backman M, Machonova O, et al. A dynamic gradient of Wnt signaling controls initiation of neurogenesis in the mammalian cortex and cellular specification in the hippocampus. Dev Biol, 2007; 311, 223-37.
[41] Kiewisz J, Kaczmarek MM, Andronowska A, et al. Gene expression of WNTs, β-catenin and E-cadherin during the periimplantation period of pregnancy in pigs-involvement of steroid hormones. Theriogenology, 2011; 76, 687-99.
[42] Pollheimer J, Loregger T, Sonderegger S, et al. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol, 2006; 168, 1134-47.
[43] Shin J, Shin Y, Oh SM, et al. MiR-29b controls fetal mouse neurogenesis by regulating ICAT-mediated Wnt/β-catenin signaling. Cell Death Dis, 2014; 5, e1473.
[44] Zhang XT, Zhao JH, Chang T, et al. Ketamine exerts neurotoxic effects on the offspring of pregnant rats via the Wnt/β-catenin pathway. Environ Sci Pollut Res, 2020; 27, 305-14.
[45] McMahon AP, Bradley A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell, 1990; 62, 1073-85.
[46] McMahon AP, Joyner AL, Bradley A, et al. The midbrain-hindbrain phenotype of mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell, 1992; 69, 581-95.
[47] Kim SE, Robles-Lopez K, Cao XY, et al. Wnt1 lineage specific deletion of Gpr161 results in embryonic midbrain malformation and failure of craniofacial skeletal development. Front Genet, 2021; 12, 761418.
[48] Brault V, Moore R, Kutsch S, et al. Inactivation of theβ-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development, 2001; 128, 1253-64.
[49] Takada S, Stark KL, Shea MJ, et al. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev, 1994; 8, 174-89.
[50] Chalamalasetty RB, Ajima R, Garriock RJ, et al. A new gain-of-function mouse line to study the role of Wnt3a in development and disease. Genesis, 2016; 54, 497-502.
[51] Mattes B, Weber S, Peres J, et al. Wnt3 and Wnt3a are required for induction of the mid-diencephalic organizer in the caudal forebrain. Neural Dev, 2012; 7, 12.
[52] Ng XW, Teh C, Korzh V, et al. The secreted signaling protein Wnt3 is associated with membrane domains in vivo: a SPIM-FCS study. Biophys J, 2016; 111, 418-29.
[53] Krylova O, Herreros J, Cleverley KE, et al. WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons. Neuron, 2002; 35, 1043-56.
[54] Braun MM, Etheridge A, Bernard A, et al. Wnt signaling is required at distinct stages of development for the induction of the posterior forebrain. Development, 2003; 130, 5579-87.
[55] Lie DC, Colamarino SA, Song HJ, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature, 2005; 437, 1370-5.
[56] Schmitt AM, Shi J, Wolf AM, et al. Wnt-Ryk signalling mediates medial-lateral retinotectal topographic mapping. Nature, 2006; 439, 31-7.
[57] Lewis SL, Khoo PL, De Young RA, et al. Dkk1 and Wnt3 interact to control head morphogenesis in the mouse. Development, 2008; 135, 1791-801.
[58] Liu PT, Wakamiya M, Shea MJ, et al. Requirement for Wnt3 in vertebrate axis formation. Nat Genet, 1999; 22, 361-5.
[59] Anne SL, Govek EE, Ayrault O, et al. WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation. PLoS One, 2013; 8, e81769.
[60] Niemann S, Zhao CF, Pascu F, et al. Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. Am J Hum Genet, 2004; 74, 558-63.
[61] Ramos-Fernández E, Tapia-Rojas C, Ramírez VT, et al. Wnt-7a stimulates dendritic spine morphogenesis and PSD-95 expression through canonical signaling. Mol Neurobiol, 2019; 56, 1870-82.
[62] López-Escobar B, Cano DA, Rojas A, et al. The effect of maternal diabetes on the Wnt-PCP pathway during embryogenesis as reflected in the developing mouse eye. Dis Model Mech, 2015; 8, 157-68.
[63] Wang YS, Nathans J. Tissue/planar cell polarity in vertebrates: new insights and new questions. Development, 2007; 134, 647-58.
[64] Rocha PP, Scholze M, Bleiß W, et al. Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling. Development, 2010; 137, 2723-31.
[65] De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Bioch Bioph Sin, 2011; 43, 745-56.
[66] Huybrechts Y, Mortier G, Boudin E, et al. WNT signaling and bone: lessons from skeletal dysplasias and disorders. Front Endocrinol, 2020; 11, 165.
[67] Stamateris RE, Rafiq K, Ettensohn CA. The expression and distribution of Wnt and Wnt receptor mRNAs during early sea urchin development. Gene Expr Patterns, 2010; 10, 60-4.
[68] Hutchins BI, Li L, Kalil K. Wnt/calcium signaling mediates axon growth and guidance in the developing corpus callosum. Dev Neurobiol, 2011; 71, 269-83.
[69] Bian WJ, Miao WY, He SJ, et al. A novel Wnt5a-Frizzled4 signaling pathway mediates activity-independent dendrite morphogenesis via the distal PDZ motif of Frizzled 4. Dev Neurobiol, 2015; 75, 805-22.
[70] Zhang YZ, Goss AM, Cohen ED, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet, 2008; 40, 862-70.
[71] Roy S, Liu FJ, Arav-Boger R. Human cytomegalovirus inhibits the PARsylation activity of tankyrase--a potential strategy for suppression of the Wnt pathway. Viruses, 2016; 8, 8.
[72] Willert K, Jones KA. Wnt signaling: is the party in the nucleus?. Genes Dev, 2006; 20, 1394-404.
[73] LaMarca HL, Nelson AB, Scandurro AB, et al. Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta, 2006; 27, 137-47.
[74] Tabata T, McDonagh S, Kawakatsu H, et al. Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis. Placenta, 2007; 28, 527-37.
[75] Liu T, Chen SH, Chen JJ, et al. In vitro study on human cytomegalovirus affecting early pregnancy villous EVT's invasion function. Virol J, 2011; 8, 114.
[76] Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science, 1994; 266, 1508-18.
[77] Van Zuylen WJ, Ford CE, Wong DDY, et al. Human cytomegalovirus modulates expression of noncanonical Wnt receptor ROR2 to alter trophoblast migration. J Virol, 2016; 90, 1108-15.
[78] Pata D, Buonsenso D, Turriziani-Colonna A, et al. Role of valganciclovir in children with congenital CMV infection: a review of the literature. Children, 2023; 10, 1246.
[79] Piret J, Boivin G. Management of cytomegalovirus infections in the era of the novel antiviral players, Letermovir and Maribavir. Infect Dis Rep, 2024; 16, 65-82.
[80] Marty FM, Ljungman P, Chemaly RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med, 2017; 377, 2433-44.
[81] Gourin C, Alain S, Hantz S. Anti-CMV therapy, what next? A systematic review. Front Microbiol, 2023; 14, 1321116.
[82] Huang SN, Zhou YP, Jiang X, et al. Hearing loss caused by HCMV infection through regulating the Wnt and notch signaling pathways. Viruses, 2021; 13, 623.
[83] Ornaghi S, Davis JN, Gorres KL, et al. Mood stabilizers inhibit cytomegalovirus infection. Virology, 2016; 499, 121-35.
[84] Møller R, Schwarz TM, Noriega VM, et al. miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2. Proc Natl Acad Sci USA, 2018; 115, 1069-74.
[85] Xiao J, Deng J, Zhang Q, et al. Targeting human cytomegalovirus IE genes by CRISPR/Cas9 nuclease effectively inhibits viral replication and reactivation. Arch Virol, 2020; 165, 1827-35.
[86] Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol, 2018; 42, 149-54.